Associate Director, PBM/Payer Contract Strategy and Analytics (US) at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalIndustries

Requirements

Highly skilled and experienced in contract strategy and analytics within Global Pricing organization
Deep understanding of BMS’ product portfolio, profitability objectives, customer profiles, and the business environment
Ability to perform sophisticated financial modeling, contract risk assessment analysis, and preparation of legally approved contract documents
Expertise in evaluating customer contracting opportunities, competitive contracting models, and developing innovative, competitive negotiation positions
Knowledge of Gross to Net (GTN) budget, projection assessments, accruals, and input for Government Pricing calculations
Ability to stay abreast of channel dynamics and ecosystem changes to identify value-creating contracting opportunities
Strong collaboration skills to work with National Account teams (NAE/MASA), brand teams, Pricing Strategy, Access Strategy, Legal, Finance, and other stakeholders
Capability to accompany National Account Executives on contracting calls and represent BMS interests in negotiations
Ensures contracts are competitive, legally compliant, strategically structured, consistent with brand strategy, and support pull-through efforts/value programs

Responsibilities

Support field-facing National PBM/GPO Account team in developing and executing strategic, value-creating, and innovative contracting solutions for Commercial and Part D customers to meet BMS financial targets
Lead evaluation and analysis of customer contracting opportunities, including financial modeling, contract risk assessment, and preparation of legally approved contract documents
Work closely with National Account teams, brand team colleagues, Pricing Strategy, and Access Strategy to ensure offers are competitive, legally compliant, and create value for customers and BMS
Serve as internal expert on assigned customers in partnership with National Account teams
Provide analysis of competitive contracting models and create contracting recommendations balancing customer and BMS needs while remaining competitive
Develop and analyze contracting scenarios to assist MASA Account teams in building strong customer partnerships
Accompany NAE on contracting calls to represent BMS interests in negotiations
Provide account-specific evaluation and development of GTN budget/projection assessments, accruals, and input for Government Pricing calculations
Interface with MASA Directors/ED, Access Strategy Directors/SD, Pricing Strategy leaders, VP for Pricing Execution, Government reporting ED, Legal, and Finance
Conduct sophisticated analyses of contracted vs. non-contracted revenue from BMS and customer perspectives
Work closely with NAE and integrated customer team to evaluate options and strategies for value-creating opportunities
Lead cross-matrix meetings with Brand Marketing, Access Strategy, Pricing Strategy, Finance, and NAE to present and gain alignment (incomplete in JD: "present and ga")

Skills

Financial Modeling

Contract Risk Assessment

Pricing Strategy

Access Strategy

Analytics

PBM Contracts

GPO Accounts

Strategic Contracting

Contract Negotiation

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free